Related references
Note: Only part of the references are listed.Pragmatic approaches to therapy for systemic lupus erythematosus
Wen Xiong et al.
NATURE REVIEWS RHEUMATOLOGY (2014)
Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents
Ricardo P. Garay et al.
EXPERT OPINION ON DRUG DELIVERY (2012)
Treatment targets in systemic lupus erythematosus: biology and clinical perspective
Valentin Marian et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Biological Therapy in Systemic Lupus Erythematosus
Mariana Postal et al.
INTERNATIONAL JOURNAL OF RHEUMATOLOGY (2012)
Current and novel therapeutics in the treatment of systemic lupus erythematosus
Cagri Yildirim-Toruner et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies
G. Ruiz-Irastorza et al.
LUPUS (2011)
Anti-CD40L Immune Complexes Potently Activate Platelets In Vitro and Cause Thrombosis in FCGR2A Transgenic Mice
Liza Robles-Carrillo et al.
JOURNAL OF IMMUNOLOGY (2010)
The effect of anti-CD40 ligand in immune thrombocytopenic purpura
Vivek L. Patel et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Effect of a single injection of humanized anti-CD154 monoclonal antibody on the platelet-specific autoimmune response in patients with immune thrombocytopenic purpura
M Kuwana et al.
BLOOD (2004)
The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway
E Toubi et al.
AUTOIMMUNITY (2004)
A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis
DT Boumpas et al.
ARTHRITIS AND RHEUMATISM (2003)
Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD154 - A randomized, double-blind, placebo-controlled trial
KC Kalunian et al.
ARTHRITIS AND RHEUMATISM (2002)
CD40L overexpression on T cells and monocytes from patients with systemic lupus erythematosus is resistant to calcineurin inhibition
CG Katsiari et al.
LUPUS (2002)
Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand
T Kawai et al.
NATURE MEDICINE (2000)
Share Paper
